Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Food and Drug Administration (FDA)
Hilary Duff Finds She is Allergic to Scallops — But Are...
Dave Bloom
-
2023/01/11
A shout out to Hilary and a quick lesson in allergen labeling.
Recall of Epinephrine Powder Used as a Precursor to Injectable Epinephrine
Dave Bloom
-
2023/01/10
It is unknown which downstream customers are affected.
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...
Dave Bloom
-
2022/12/26
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Mom, Who Lost Son to Anaphylaxis from Movie Popcorn, Spearheads Campaign...
Dave Bloom
-
2022/12/14
"Judith's Wish" is a campaign calling for stricter allergen labeling in the UK
FDA Issues Important New Draft Guidance on Allergen Labeling After 16...
Dave Bloom
-
2022/12/01
Must read if you are concerned with food allergies, intolerances, or celiac disease.
Woman Suffers Severe Reaction from Lip Filler, FDA Warned Against Using...
Dave Bloom
-
2022/10/27
Her TikTok documenting the experience has already garnered some 20 million views.
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...
Dave Bloom
-
2022/10/21
If approved, acceptance targeted for mid-2023.
Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...
News Wire ~ 3rd Party Press Release
-
2022/10/12
Response confirms approach and supports the characterization of their novel drug platform.
Private Law Firm to Investigate Claims on Behalf of Investors in...
Dave Bloom
-
2022/09/23
It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial
Dave Bloom
-
2022/09/22
Another delay for the long-awaited therapy.
1
2
3
...
21
Page 1 of 21